The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Anxiety Is an Independent Risk Factor for Bone Fractures

Anxiety Is an Independent Risk Factor for Bone Fractures

November 18, 2018 • By Mary Beth Nierengarten

  • Tweet
  • Email
Print-Friendly Version / Save PDF
MikeDotta / shutterstock.com

MikeDotta / shutterstock.com

Higher anxiety levels in postmenopausal women may put them at increased risk of fracture and should be considered when assessing a woman’s risk of osteoporosis as well. This is the conclusion of a study recently published in the journal Menopause that looked at the role of anxiety in bone health.1 Specifically, the study examined the link between anxiety levels and bone mineral density (BMD) and fracture risk among postmenopausal women.

You Might Also Like
  • Baseline Bone Measures Predict Risk of Fragility Fracture in Postmenopausal
  • Women on Osteoporosis Drugs Still Need Bone Density Screenings
  • Serum Bone Markers CTX, PINP Not Linked with Hip Fracture Risk in Osteoporosis
Explore This Issue
November 2018
Also By This Author
  • Atacicept Shows Promise in Lupus Treatment Trials

Previous research has focused mainly on the psychological effects of osteoporosis and fracture on quality of life and anxiety levels, according to lead author of the study, Antonino Catalano, MD, PhD, Department of Clinical and Experimental Medicine, University Hospital of Messina, Messina, Italy. Dr. Catalano notes data from this research suggest that “in comparison with healthy women, osteoporotic women show a weakened quality of life and increased anxiety levels.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

What has not been looked at and what is new in this study is how anxiety levels may influence fracture risk. “We looked in the direction from anxiety levels to bone health [in postmenopausal women],” says Dr. Catalano.

The study found higher anxiety levels in postmenopausal women were linked to low bone mineral density and higher fracture risk, independent of other classical risk factors for osteoporosis, such as age, menopausal age, years since menopause and body mass index.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Our findings suggest a possible new clinical risk factor for osteoporosis that could be measured to improve our ability to identify women at risk for fractures,” says Dr. Catalano.

The Study

The cross-sectional study included 192 white women recruited from a single institution in Messina, Italy. All women underwent evaluation to assess their anxiety level by completing 14 symptom-defining elements of anxiety included in the Hamilton Anxiety Rating Scale (HAMA). These elements include psychological symptoms of anxiety (e.g., tension, fear, sleep and memory issues, and depression), somatic symptoms of anxiety (e.g., aches and pains, ear or eye problems, chest tightness, gastrointestinal symptoms), as well as observed behaviors (e.g., fidgety or restlessness). Based on the results, women were grouped by level from mild (HAMA-1; n=87) to moderate (HAMA-2; n=48) to severe anxiety (HAMA-3; n=57).

All women also underwent evaluation to assess bone mineral density using standard imaging, as well as fracture risk using a computer-based algorithm (i.e., the Fracture Risk Assessment Tool) that calculates the 10-year probability of a major fracture.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The study found the women with the lowest levels of anxiety (HAMA-1) had a significantly lower 10-year probability of a major fracture compared with women who had the highest levels of anxiety (HAMA-3) (20.44% vs. 24.94%, respectively; P=0.03). Women with moderate levels of anxiety (HAMA-2) also had a significantly lower probability of fracture risk than the women with the highest anxiety levels (17.91% vs. 24.94%, respectively; P=0.002).

Women with the highest levels of anxiety also had significantly lower BMD than women with the lowest levels of anxiety. When looking at bone density of the lumbar spine and femoral neck, women with the highest anxiety levels had significantly lower T-score values than women at the lowest levels of anxiety (see Table 1).

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Research Reviews Tagged With: OsteoporosisIssue: November 2018

You Might Also Like:
  • Baseline Bone Measures Predict Risk of Fragility Fracture in Postmenopausal
  • Women on Osteoporosis Drugs Still Need Bone Density Screenings
  • Serum Bone Markers CTX, PINP Not Linked with Hip Fracture Risk in Osteoporosis
  • Growth Hormone Reduces Fractures in Women with Osteoporosis

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)